Fanconi anemia is a highly penetrant cancer susceptibility syndrome

Haematologica

Volumn 93, Issue 4, 2008, Pages 486-489

  Dokal, Inderjeet ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CYCLOPHOSPHAMIDE; FANCONI ANEMIA PROTEIN; FLUDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ATAXIA TELANGIECTASIA; BONE MARROW DEPRESSION; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME BREAKAGE; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DRUG DOSE REDUCTION; EDITORIAL; FANCONI ANEMIA; GENE MUTATION; HEMATOPOIETIC STEM CELL; HOMOLOGOUS RECOMBINATION; HUMAN; PROTEIN PROTEIN INTERACTION; RISK FACTOR; STEM CELL TRANSPLANTATION;

BONE MARROW DISEASES; CHROMOSOME BREAKAGE; COHORT STUDIES; DISEASE PROGRESSION; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASMS; NEOPLASTIC SYNDROMES, HEREDITARY; PENETRANCE; REGISTRIES; RISK;

EID: 42149133107     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12734     Document Type: Editorial

References (20)

1. Auerbach AD, Buchwald M, Joenje H. In: The Metabolic and Molecular Basis Of Inherited Disease (eds CR Scriver et al.) 2001, pp753-768. McGraw-Hill, New York.
2. Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia-clinical and molecular aspects. Br J Haematol 2004;126:176-91.
3. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol 2006;43:147-56.
4. Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 2004;103:2493-503.
5. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nature Rev Genet 2007;6:735-48.
6. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER 3rd, Hurov KE, Luo J, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007;129:289-301.
7. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297:606-9.
8. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nature Genet 2007 39:142-143.
9. Cohn MA, Kowal P, Yang K, Haas W, Huang TT, Gygi SP, et al. A UAF1-Containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell 2007;28:786-97.
10. Li X, Leteurtre F, Rocha V, Guardiola P, Berger R, Daniel MT, et al. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia. Br J Haematol 2003;120:836-45.
11. Briot D, Mace-Aime G, Subra F, Rosselli F. Aberrant activation of stress response pathways leads to TNF-α oversecretion in Fanconi anemia. Blood 2008; 111:1913-23.
12. Rosenberg PS, Alter BP, Ebell W. Cancer risks in Fanconi anemia: experience of the German Fanconi Anemia (GEFA) Registry. Haematologica 2008;93:511-7.
13. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-6.
14. Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, et al. Association of complementation group and mutation type with clinical outcome in Fanconi anaemia. European Fanconi Anemia Research Group. Blood 2000;96:4064-70.
15. Gillio AP, Verlander PC, Batish SD, Giampietro PF, Auerbach AD. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry Study. Blood 1997:90:105-10.
16. de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IA, Rahemtulla A, et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003; 32:653-6.
17. Motwani J, Lawson SE, Darbyshire PJ. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia - experience in a single UK centre. Bone Marrow Transplant 2005;36:405-10.
18. Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007;109:2256-62.
19. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. PALB2, which encodes a BRCA2-interacting protein is a cancer susceptibility gene. Breast Cancer Susceptibility Collaboration (UK). Nat Genet 2007;39:165-7.
20. Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2003;95:1718-21.